Combination therapies in spondyloarthropathies

Kobe Journal of Medical Sciences

Volumn 50, Issue 1-2, 2004, Pages 31-37

  Çalgüneri, Meral ^a   Çobankara, Veli ^a   Öztürk, M Akif ^a   Ertenli, Ihsan ^a   Kiraz, Sedat ^a   Apraş, Şule ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Combination therapy; Hydroxychloroquine; Methotrexate; Spondyloarthropathy; Sulfasalazine

Indexed keywords

ANALGESIC AGENT; ANTIMALARIAL AGENT; DICLOFENAC; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FOLIC ACID; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

ADULT; ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PSORIATIC ARTHRITIS; SIDE EFFECT; SPONDYLOARTHROPATHY; STOMATITIS; TREATMENT OUTCOME;

ADULT; ARTHRITIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYCHLOROQUINE; MALE; METHOTREXATE; SPONDYLARTHROPATHIES; SULFASALAZINE; TREATMENT OUTCOME;

EID: 12344260863     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. van der Linden S., and van der Heijde D. 2001. Ankylosing Spondylitis, p. 1039-1053. In Ruddy S., Harris ED Jr., Sledge C.B. (eds), Textbook of Rheumatology, sixth ed. WB Saunders, Philadelphia, USA.
2. Dougados M., van der Linden S., Leirisal-Repo M., Huitfeldt B., Juhlin R., Veys E., Zeidler H., Kvien T.K., Olivieri I., Dijkmans B., et al. 1995. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 38: 618-627.
3. Creemers M.C.W., van Riel P.L.C.M., Franssen M.J.A.M., van der Putte L.B.A., and Gribnau F.W.J. 1994. Second-line treatment in seronegative spondylarthropathies. Semin Arthritis Rheum 24: 71-81.
4. Nissila M., Lehtinen K., Leirisalo-Repo M., Luukkainen R., Mutru O., and Yli-Kerttula U. 1988. Sulfasalazine in the treatment of ankylosing spondylitis; a twenty-six-week, placebo controlled clinical trial. Arthritis Rheum 31: 1111-1116.
5. Clegg D.O., Reda D.J., and Abdellatif M. 1999. Comparison of Sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondyloarthropathies: a department of veterans affairs cooperative study. Arthritis Rheum 42: 2325-2329.
6. Sampaio-Barros P.D., Costallant L.T.L., Bertolo M.B., Neto J.F.M., and Samara A.M. 2000. Methotrexate in the treatment of ankylosing spondylitis. Scan J Rheumatol 29: 160-162.
7. Biasi D., Carletto A., Caramaschi P., Pacor M.L., Maleknia T., and Bambara L.M. 2000. Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study. Clin Rheumatol 19: 114-117.
8. Sayers M.E., and Mazanec D.J. 1992. Use of antimalarial drugs for the treatment of psoriatic arthritis. Am J Med 93: 474-475.
9. Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., Cats A., Dijkmans B., Olivieri I., Pasero G., Veys E., and Zeidler H. 1991. The European spondyloarhtopathy Study Group preliminary criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 34:1218-1227.
10. MacRae I.F., and Wright V. 1969. Measurement of back movement. Ann Rheum Dis 28: 584-589.
11. Toussirot E., and Wendling D. 2001. Therapeutic advances in ankylosing spondylitis. Expert Opin Investig Drugs 10: 21-29.
12. Rynes R.I. 1997. Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol 36: 799-805.
13. Kammer G.M., Soter N.A., Gibson D.J., and Schur P.H. 1979. Psoriatic arthritis: A clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 9: 75-97.
14. Giordano M. 1982. Long-term prophylaxis of recurring spondylitic iridocyclitis with antimalarials. Z Rheumatol 41: 105-106.
15. Espinoza L.R., Cuellar M.L., Mendez E., and Angulo J. 1998. Combination therapy of methotrexate (MTX) and cyclosporin-A (CYC-A) in refractory psoriatic arthritis (PsA). Arthritis Rheum 41 (Suppl): S335.
16. Mazzanti G., Coloni L., De Sabbata G., and Paladini G. 1994. Methotrexate and cyclosporine combined therapy in severe psoriatic arthritis. A pilot study. Acta Derm Venereol (Stockh) 186 (Suppl): 116.
17. Smedegard G., and Bjork J. 1995. Sulphasalazine: Mechanism of action in rheumatoid arthritis. Br J Rheumatol 34 (suppl. 2): 7-15.
18. Weinblatt M.E. 1995. Efficacy of methotrexate in rheumatoid arthritis. Br J Rheumatol 34 Suppl 2: 43-48.
19. Nisar M., Carlisle L., and Amos R.S. 1994. Methotrexate and sulfasalazine as combination therapy in rheumatoid arthritis. Br J Rheumatol 1994; 33: 651-654.
20. Fries J.F., Singh G., Lenert L., and Furst D. 1990. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum 33: 1611-1619.
21. Çalgüneri M., Pay S., Çalişkaner Z., Apraş, Ş., Kiraz S., Ertenli I., and Çobankara V. 1999. Combination therapy in rheumatoid arthritis. Clin Exp Rheumatol 17: 699-704.
22. O'Dell J.R., Haire C.E., Erikson N., Drymalski W., Palmer W., Eckhoff P.J., Garwood V., Maloley P., Klassen L.W., Wees S., Klein H., and Moore G.F. 1996. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 334: 287-1291.